Case Study 2: HPI: Ms. Juggenmeir is a 71–year old Female who comes into your office with concerns of fatigue and dry skin. She is a retired Banker. She is AAOx4, ambulatory, and lives by herself. She does report increased fatigue no matter how much sleep she gets. She is also concerned that she may need to come off of one of her meds because her hair is thinning. She had labs done and also was informed they would review results at this visit. Other pertinent diagnoses include Hypertension, Hyperlipidemia, and Vitamin D deficiency. She admits to not taking her vitamin d daily as prescribed.
Case Study 2: HPI: Ms. Juggenmeir is a 71–year old Female who comes into your office with concerns of fatigue and dry skin. She is a retired Banker. She is AAOx4, ambulatory, and lives by herself. She does report increased fatigue no matter how much sleep she gets. She is also concerned that she may need to come off of one of her meds because her hair is thinning. She had labs done and also was informed they would review results at this visit. Other pertinent diagnoses include Hypertension, Hyperlipidemia, and Vitamin D deficiency. She admits to not taking her vitamin d daily as prescribed. RESOURCE FOR THIS WEEK: Review Endocrine-related Evidence Based Practice Guidelines. Ms. Juggenmeir is a 71 y/o female who is AAOX4. She makes no unusual motor movements and demonstrates no tics. She denies any visual or auditory hallucinations. She denies any suicidal thoughts or ideations. She denies any falls or pain. (All other Review of System and Physical Exam findings are negative other than stated.) Vital Signs: BP 137/82, HR 89, RR 20, Temp 98.1 PMH: Hypertension, Hyperlipidemia, Vitamin D deficiency Allergies: I.V. Contrast, ACE Inhibitors Medications: Women’s One A Day-Multivitamin daily Chlorthalidone 25mg daily Fish Oil 1 tablet daily Amlodipine 5mg p.o. daily Losartan 100mg p.o. daily Atorvastatin 40mg p.o. at bedtime daily Aspirin 81mg p.o. daily Ergocalciferol 50,000 units PO once a month Social History: as stated in Case Study ROS: as stated in Case study Diagnostics/Assessments done:TEST RESULT REFERENCE RANGE GLUCOSE 85 65-99 SODIUM 134 135-146 POTASSIUM 4.2 3.5-5.3 CHLORIDE 104 98-110 CARBON DIOXIDE 29 19-30 CALCIUM 9.0 8.6- 10.3 BUN 20 7-25 CREATININE 1.01 0.70-1.25 GLOMERULAR FILTRATION RATE (eGFR 76 >or=60 mL/min/1.73m2 TEST RESULT REFERENCE RANGE TSH 23 0.4-4.0 FREE T4 0.05 0.9-2.4 mcg/dl T3 3.0 2.0-4.4 ng/dl Vitamin D 1,25 OH 14 36-144 TEST RESULT REFERENCE RANGE WBC 7.3 3.4- 10.8 RBC 4.31 135-146 HEMOGLOBIN 14 13-17.2 HEMATOCRIT 42% 36-50 MCV 90 80-100 MCHC 34 32-36 PLATELET 272 150-400
- CXR- Last cxr showed no cardiopulmonary findings. WNL
- TSH/Free T4, T3- as noted below in lab results
- Basic Metabolic Panel and CBC as shown below
- Vitamin D Level- as noted below in lab results
- Subjective: What was the patient’s subjective complaint? What details did the patient provide regarding their history of present illness and personal and medical history? Include a list of prescription and over-the-counter drugs the patient is currently taking. Compare this list to the American Geriatrics Society Beers Criteria®, and consider alternative drugs if appropriate. Provide a review of systems.
- Objective: What observations did you note from the physical assessment? What were the lab, imaging, or functional assessments results?
- Assessment: Provide a minimum of three differential diagnoses. List them from top priority to least priority. Compare the diagnostic criteria for each, and explain what rules each differential in or out. Explain you critical thinking process that led you to the primary diagnosis you selected. Include pertinent positives and pertinent negatives for the specific patient case.
- Plan: Provide a detailed treatment plan for the patient that addresses each diagnosis, as applicable. Include documentation of diagnostic studies that will be obtained, referrals to other health-care providers, therapeutic interventions, education, disposition of the patient, caregiver support, and any planned follow-up visits. Provide a discussion of health promotion and disease prevention for the patient, taking into consideration patient factors, past medical history (PMH), and other risk factors. Finally, include a reflection statement on the case that describes insights or lessons learned
Our Advantages
- Quality Work
- Unlimited Revisions
- Affordable Pricing
- 24/7 Support
- Fast Delivery
Order Now